loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 22106 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 DORIPENEM (2)

filter

01 SHIONOGI INC (2)

filter

01 INJECTABLE;INTRAVENOUS (2)

filter

01 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

02 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

filter

01 USA (2)

URL Supplier Web Content
INJECTABLE;INTRAVENOUS
500MG/VIAL **Federal R...
DORIBAX
USA
22106
2007-10-12
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
INJECTABLE;INTRAVENOUS
250MG/VIAL **Federal R...
DORIBAX
USA
22106
2010-10-05
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 22106

Looking for CTD TGA MCC DOSSIER APPLICATION 22106 2

19

Shionogi, based in Japan, is a pharmaceutical company.

One of their notable products is DORIPENEM, with a corresponding application number 22106 and regulatory information .

proudly manufactured in the

approval since 2007-10-12

Shionogi's DORIBAX INJECTABLE;INTRAVENOUS, medication with 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of DORIPENEM.

18

Shionogi, based in Japan, is a pharmaceutical company.

One of their notable products is DORIPENEM, with a corresponding application number 22106 and regulatory information .

proudly manufactured in the

approval since 2010-10-05

Shionogi's DORIBAX INJECTABLE;INTRAVENOUS, medication with 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of DORIPENEM.

Post Enquiry
POST ENQUIRY